Nitric oxide and major depression

Yun, 1997, Nitric oxide in health and disease of the nervous system, Mol. Psychiatry, 2, 300, 10.1038/sj.mp.4000272

Esplugues, 2002, NO as a signalling molecule in the nervous system, Br. J. Pharmacol., 135, 1079, 10.1038/sj.bjp.0704569

Li, 2005, Structure-function studies on nitric oxide synthases, J. Inorg. Biochem., 99, 293, 10.1016/j.jinorgbio.2004.10.016

McLeod, 2001, Nitric oxide, stress, and depression, Psychopharmacol. Bull., 35, 24

Lee, 2006, Increased plasma nitric oxide metabolites in suicide attempters, Neuropsychobiology, 53, 127, 10.1159/000092542

Suzuki, 2001, Elevated plasma nitrate levels in depressive states, J. Affect Disord., 63, 221, 10.1016/S0165-0327(00)00164-6

Joca, 2006, Inhibition of neuronal nitric oxide synthase in the rat hippocampus induces antidepressant-like effects, Psychopharmacology (Berl), 185, 298, 10.1007/s00213-006-0326-2

Dhir, 2007, Involvement of nitric oxide (NO) signaling pathway in the antidepressant action of bupropion, a dopamine reuptake inhibitor, Eur. J. Pharmacol., 568, 177, 10.1016/j.ejphar.2007.04.028

Yildiz, 2000, Antidepressant-like effect of 7-nitroindazole in the forced swimming test in rats, Psychopharmacology (Berl), 149, 41, 10.1007/s002139900316

Mutlu, 2009, Effects of neuronal and inducible NOS inhibitor 1-[2-(trifluoromethyl) phenyl] imidazole (TRIM) in unpredictable chronic mild stress procedure in mice, Pharmacol. Biochem. Behav., 92, 82, 10.1016/j.pbb.2008.10.013

Wegener, 2000, Endogenous nitric oxide decreases hippocampal levels of serotonin and dopamine in vivo, Br. J. Pharmacol., 130, 575, 10.1038/sj.bjp.0703349

Harkin, 2004, Nitric oxide inhibitors augment the effects of serotonin re-uptake inhibitors in the forced swimming test, Eur. Neuropsychopharmacol., 14, 274, 10.1016/j.euroneuro.2003.08.010

Finkel, 1996, Paroxetine is a novel nitric oxide synthase inhibitor, Psychopharmacol. Bull., 32, 653

Umathe, 2009, Role of nitric oxide in obsessive–compulsive behavior and its involvement in the anti-compulsive effect of paroxetine in mice, Nitric Oxide, 21, 140, 10.1016/j.niox.2009.07.001

Oliveira, 2008, Expression of neuronal nitric oxide synthase in the hippocampal formation in affective disorders, Braz. J. Med. Biol. Res., 41, 333, 10.1590/S0100-879X2008000400012

Karolewicz, 1991, Nitric oxide synthase inhibitors have antidepressant-like properties in mice. 2. Chronic treatment results in downregulation of cortical beta-adrenoceptors, Eur. J. Pharmacol., 372, 215, 10.1016/S0014-2999(99)00192-2

Kaster, 2005, Effect of potassium channel inhibitors in the forced swimming test: possible involvement of l-arginine–nitric oxide–soluble guanylate cyclase pathway, Behav. Brain Res., 165, 204, 10.1016/j.bbr.2005.06.031

Wong, 2006, Phosphodiesterase genes are associated with susceptibility to major depression and antidepressant treatment response, Proc. Natl. Acad. Sci. USA, 103, 15124, 10.1073/pnas.0602795103

Eby, 2006, Rapid recovery from major depression using magnesium treatment, Med. Hypotheses, 67, 362, 10.1016/j.mehy.2006.01.047

Pozo, 1994, Physiological concentrations of melatonin inhibit nitric oxide synthase in rat cerebellum, Life Sci., 55, PL455, 10.1016/0024-3205(94)00532-X

Serfaty, 2010, A randomized double-blind placebo-controlled trial of treatment as usual plus exogenous slow-release melatonin (6mg) or placebo for sleep disturbance and depressed mood, Int. Clin. Psychopharmacol., 25, 132, 10.1097/YIC.0b013e32832c260b

Leon, 2006, Inhibition of neuronal nitric oxide synthase activity by N1-acetyl-5-methoxykynuramine, a brain metabolite of melatonin, J. Neurochem., 98, 2023, 10.1111/j.1471-4159.2006.04029.x

De Berardis, 2011, The emerging role of melatonin agonists in the treatment of major depression: focus on agomelatine, CNS Neurol. Disord. Drug Targets, 10, 119, 10.2174/187152711794488674

Karolewicz, 2004, Low nNOS protein in the locus coeruleus in major depression, J. Neurochem., 91, 1057, 10.1111/j.1471-4159.2004.02792.x

Chrapko, 2004, Decreased platelet nitric oxide synthase activity and plasma nitric oxide metabolites in major depressive disorder, Biol. Psychiatry, 56, 129, 10.1016/j.biopsych.2004.03.003

Ikenouchi-Sugita, 2009, Opposite effects of milnacipran, a serotonin norepinephrine reuptake inhibitor, on the levels of nitric oxide and brain-derived neurotrophic factor in mouse brain cortex, Naunyn Schmiedebergs Arch. Pharmacol., 380, 479, 10.1007/s00210-009-0467-z

Paul, 2003, Glutamate and depression: clinical and preclinical studies, Ann. NY Acad. Sci., 1003, 250, 10.1196/annals.1300.016

Patel, 2010, Norepinephrine and nitric oxide promote cell survival signaling in hippocampal neurons, Eur. J. Pharmacol., 633, 1, 10.1016/j.ejphar.2010.01.012

Seilicovich, 1995, Nitric oxide inhibits the release of norepinephrine and dopamine from the medial basal hypothalamus of the rat, Proc. Natl. Acad. Sci. USA, 92, 11299, 10.1073/pnas.92.24.11299

Kaye, 1997, Regulation of neuronal (uptake-1 mediated norepinephrine transport by nitric oxide: mechanism and influence of autocrine and paracrine sources of nitric oxide, Am. J. Physiol., 272, H875

Ikenouchi-Sugita, 2009, Effects of antidepressants on plasma metabolites of nitric oxide in major depressive disorder: comparison between milnacipran and paroxetine, Prog. Neuropsychopharmacol. Biol. Psychiatry, 33, 1451, 10.1016/j.pnpbp.2009.07.028

Karolewicz, 2001, Effect of NOS inhibitor on forced swim test and neurotransmitters turnover in the mouse brain, Pol. J. Pharmacol., 53, 587

Zhang, 2010, Neuronal nitric oxide synthase alteration accounts for the role of 5-HT1A receptor in modulating anxiety-related behaviors, J. Neurosci., 30, 2433, 10.1523/JNEUROSCI.5880-09.2010

Ulak, 2010, Involvement of serotonin receptor subtypes in the antidepressant-like effect of trim in the rat forced swimming test, Pharmacol. Biochem. Behav., 95, 308, 10.1016/j.pbb.2010.02.006

Crespi, 2010, The selective serotonin reuptake inhibitor fluoxetine reduces striatal in vivo levels of voltammetric nitric oxide (NO): a feature of its antidepressant activity?, Neurosci. Lett., 470, 95, 10.1016/j.neulet.2009.12.049

Kiss, 2004, Inhibitory effect of nitric oxide on dopamine transporters: interneuronal communication without receptors, Neurochem. Int., 45, 485, 10.1016/j.neuint.2003.11.004

Sandor, 1995, Role of nitric oxide in modulating neurotransmitter release from rat striatum, Brain Res. Bull., 36, 483, 10.1016/0361-9230(94)00229-T

Garthwaite, 1991, Glutamate, nitric oxide and cell–cell signalling in the nervous system, Trends Neurosci., 14, 60, 10.1016/0166-2236(91)90022-M

Dawson, 1991, Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures, Proc. Natl. Acad. Sci. USA, 88, 6368, 10.1073/pnas.88.14.6368

Nei, 1996, NMDA receptor activation induces glutamate release through nitric oxide synthesis in guinea pig dentate gyrus, Brain Res., 728, 105, 10.1016/0006-8993(96)00394-0

Ergun, 2007, Prevention of pro-depressant effect of l-arginine in the forced swim test by N(G)-nitro-l-arginine and [1H-[1,2,4]oxadiazole[4,3-a]quinoxalin-1-one], Eur. J. Pharmacol., 554, 150, 10.1016/j.ejphar.2006.09.067

Spiacci, 2008, Nitric oxide-mediated anxiolytic-like and antidepressant-like effects in animal models of anxiety and depression, Pharmacol. Biochem. Behav., 88, 247, 10.1016/j.pbb.2007.08.008

Harkin, 1999, Nitric oxide synthase inhibitors have antidepressant-like properties in mice. 1. Acute treatments are active in the forced swim test, Eur. J. Pharmacol., 372, 207, 10.1016/S0014-2999(99)00191-0

Ergün, 2006, Co-administration of a nitric oxide synthase inhibitor and melatonin exerts an additive antidepressant-like effect in the mouse forced swim test, Med. Sci. Monit., 12, BR307

Heiberg, 2002, Reduction of cGMP and nitric oxide has antidepressant-like effects in the forced swimming test in rats, Behav. Brain Res., 134, 479, 10.1016/S0166-4328(02)00084-0

Brink, 2008, Appearance of antidepressant-like effect by sildenafil in rats after central muscarinic receptor blockade: evidence from behavioural and neuro-receptor studies, J. Neural Transm., 115, 117, 10.1007/s00702-007-0806-5

Dhir, 2007, Involvement of l-arginine–nitric oxide–cyclic guanosine monophosphate pathway in the antidepressant-like effect of venlafaxine in mice, Prog. Neuropsychopharmacol. Biol. Psychiatry, 31, 921, 10.1016/j.pnpbp.2007.02.008

Kulkarni, 2008, On the mechanism of antidepressant-like action of berberine chloride, Eur. J. Pharmacol., 589, 163, 10.1016/j.ejphar.2008.05.043

Jesse, 2010, Involvement of l-arginine–nitric oxide–cyclic guanosine monophosphate pathway in the antidepressant-like effect of bis selenide in the mouse tail suspension test, Eur. J. Pharmacol., 635, 135, 10.1016/j.ejphar.2010.03.019

Jesse, 2008, Involvement of l-arginine–nitric oxide–cyclic guanosine monophosphate pathway in the antidepressant-like effect of tramadol in the rat forced swimming test, Prog. Neuropsychopharmacol. Biol. Psychiatry, 32, 1838, 10.1016/j.pnpbp.2008.08.010

Ghasemi, 2009, NMDA receptor/nitrergic system blockage augments antidepressant-like effects of paroxetine in the mouse forced swimming test, Psychopharmacology (Berl), 206, 325, 10.1007/s00213-009-1609-1

Dhir, 2008, Possible involvement of nitric oxide (NO) signaling pathway in the antidepressant-like effect of MK-801(dizocilpine), a NMDA receptor antagonist in mouse forced swim test, Indian J. Exp. Biol., 46, 164

Almeida, 2006, Evidence for the involvement of l-arginine–nitric oxide–cyclic guanosine monophosphate pathway in the antidepressant-like effect of memantine in mice, Behav. Brain Res., 168, 318, 10.1016/j.bbr.2005.11.023

Rosa, 2003, Involvement of NMDA receptors and l-arginine–nitric oxide pathway in the antidepressant-like effects of zinc in mice, Behav. Brain Res., 144, 87, 10.1016/S0166-4328(03)00069-X